Cargando…
Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers
The major impediment to the delivery of therapeutics to the brain is the presence of the blood-brain barrier (BBB). The BBB allows for the entrance of essential nutrients while excluding harmful substances, including most therapeutic agents; hence, brain disorders, especially tumours, are very diffi...
Autores principales: | Caprifico, Anna E., Foot, Peter J. S., Polycarpou, Elena, Calabrese, Gianpiero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690755/ https://www.ncbi.nlm.nih.gov/pubmed/33114020 http://dx.doi.org/10.3390/pharmaceutics12111013 |
Ejemplares similares
-
Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems
por: Caprifico, Anna E., et al.
Publicado: (2022) -
Chitosan and Its Structural Modifications for siRNA Delivery
por: Al-Absi, Mona Y., et al.
Publicado: (2023) -
Nanocarriers as Potential Drug Delivery Candidates
for Overcoming the Blood–Brain Barrier: Challenges and Possibilities
por: Ahlawat, Jyoti, et al.
Publicado: (2020) -
Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances
por: Niu, Xiaoqian, et al.
Publicado: (2019) -
Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
por: Ramalho, Maria João, et al.
Publicado: (2022)